Bank of America
TSHA icon

Bank of America’s Taysha Gene Therapies TSHA Stock Holding History

Bank of America’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.5M Buy
1,677,046
+524,366
+45% +$2.44M ﹤0.01% 3169
2025
Q4 		$6.34M Sell
1,152,680
-154,607
-12% -$751K ﹤0.01% 3192
2025
Q3 		$4.27M Buy
1,307,287
+576,559
+79% +$1.63M ﹤0.01% 4161
2025
Q2 		$1.69M Buy
730,728
+93,886
+15% +$204K ﹤0.01% 4913
2025
Q1 		$885K Sell
636,842
-1,073,461
-63% -$1.8M ﹤0.01% 5307
2024
Q4 		$2.96M Buy
1,710,303
+1,576,568
+1,179% +$3.27M ﹤0.01% 4094
2024
Q3 		$269K Buy
133,735
+9,761
+8% +$21.4K ﹤0.01% 5871
2024
Q2 		$278K Sell
123,974
-1,739
-1% -$5.06K ﹤0.01% 5715
2024
Q1 		$361K Buy
125,713
+3,385
+3% +$7.05K ﹤0.01% 5547
2023
Q4 		$217K Buy
122,328
+84,148
+220% +$168K ﹤0.01% 6031
2023
Q3 		$121K Buy
38,180
+8,749
+30% +$16.3K ﹤0.01% 6166
2023
Q2 		$19.5K Sell
29,431
-107,570
-79% -$77.9K ﹤0.01% 6715
2023
Q1 		$109K Buy
137,001
+86,625
+172% +$112K ﹤0.01% 6222
2022
Q4 		$114K Sell
50,376
-19,129
-28% -$38.7K ﹤0.01% 6182
2022
Q3 		$134K Buy
69,505
+3,462
+5% +$12.6K ﹤0.01% 6200
2022
Q2 		$246K Sell
66,043
-5,315
-7% -$21.1K ﹤0.01% 5940
2022
Q1 		$465K Buy
71,358
+9,712
+16% +$72.6K ﹤0.01% 5895
2021
Q4 		$718K Buy
61,646
+28,969
+89% +$437K ﹤0.01% 5578
2021
Q3 		$608K Buy
32,677
+8,298
+34% +$158K ﹤0.01% 5493
2021
Q2 		$517K Buy
24,379
+9,524
+64% +$220K ﹤0.01% 5397
2021
Q1 		$301K Buy
14,855
+8,299
+127% +$225K ﹤0.01% 5740
2020
Q4 		$174K Buy
+6,556
New +$141K ﹤0.01% 5686

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's TSHA Position: Q1 2026 in Review

Bank of America increased its Taysha Gene Therapies (TSHA) stake by 45% in Q1 2026, buying an estimated $2.44M and bringing the position to 1,677,046 shares worth $7.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3169.

Bank of America first reported a position in TSHA in Q4 2020 and has held it in 22 quarters since. 191 funds tracked by Wall St. Rank hold TSHA as of Q1 2026.

  • Bank of America held 1,677,046 shares of Taysha Gene Therapies worth $7.5M as of Q1 2026.
  • Bank of America bought 524,366 Taysha Gene Therapies shares in Q1 2026, an estimated $2.44M.
  • Taysha Gene Therapies made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3169 holding.
  • Bank of America first reported a position in Taysha Gene Therapies in Q4 2020 and has held it in 22 quarters since.
  • 191 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.